Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maksims Vanejevs"'
Autor:
Graziella Tocco, Antonio Laus, Maksims Vanejevs, Anastasija Ture, Rafaela Mostallino, Nicholas Pintori, Maria Antonietta De Luca, M. Paola Castelli, Gaetano Di Chiara
Publikováno v:
Archiv der PharmazieREFERENCES. 356(1)
The development of novel μ-opioid receptor (MOR) antagonists is one of the main objectives of drug discovery and development. Based on a simplified version of the morphinan scaffold, 3-[3-(phenalkylamino)cyclohexyl]phenol analogs were designed, synt
Autor:
Holger Kubas, Ilya Pyatkin, Maksims Vanejevs, Ulrich Abel, Udo Meyer, Mirko Hechenberger, Valerjans Kauss, Raisa Ambartsumova, Alexey I. Polosukhin, Bjoern Krueger, Ronalds Zemribo
Publikováno v:
Bioorganicmedicinal chemistry letters. 23(16)
A virtual screening approach using various in silico methodologies led to the discovery of 2-(m-tolylamino)-7,8-dihydroquinazolin-5(6H)-one (1) as a moderately active negative allosteric modulator (NAM) of the metabotropic glutamate receptor subtype
Autor:
Claudia Jatzke, Valerjans Kauss, Maksims Vanejevs, Kate E. Gilling, Chris G. Parsons, C. Wollenburg, Aigars Jirgensons
Publikováno v:
Journal of neural transmission (Vienna, Austria : 1996). 114(12)
The fact that potent NMDA receptor channel blockers produce phencyclidine-like psychotropic symptoms in man and rodents implies that uncompetitive antagonism of NMDA receptors may not be a promising therapeutic approach. However, recent data indicate
Autor:
Maksims Vanejevs, Claudia Jatzke, Steffen Renner, Sibylle Müller, Mirko Hechenberger, Tanja Bauer, Anna Klochkova, Ilya Pyatkin, Denis Kazyulkin, Elena Aksenova, Sergey Shulepin, Olga Timonina, Ariane Haasis, Aleksandrs Gutcaits, Christopher G. Parsons, Valerjans Kauss, Tanja Weil
Publikováno v:
Journal of Medicinal Chemistry; Jan2008, Vol. 51 Issue 3, p634-647, 14p